Telemedicine brings hepatitis c care to opioid treatment clinics
NCT ID NCT06483451
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well telemedicine works to treat hepatitis C in people who are already getting care at opioid treatment programs. Researchers will review medical records from 200 patients to see how many start and finish their hepatitis C treatment. The goal is to make it easier for people with opioid use disorder to get cured of hepatitis C.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pocket-sized HIV test could bring same-day diagnosis to community clinics
- Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
- Austrian study seeks to eliminate hepatitis by linking patients to care
- Baltimore study enlists peers to fight HIV and overdose among drug users
- On-the-Spot hep c care at methadone clinics boosts cure rates
- One-Stop care: hepatitis c treatment may curb HIV and opioid risks